Mather Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Mather Group's LLY Position: Q2 2026 in Review
Mather Group reduced its Eli Lilly (LLY) stake by 15% in Q2 2026, selling an estimated $1.59M and leaving 9,132 shares worth $11M. The position accounts for 0.1% of the portfolio, ranked #100.
Mather Group first reported a position in LLY in Q1 2021 and has held it in 22 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Mather Group held 9,132 shares of Eli Lilly worth $11M as of Q2 2026.
- Mather Group sold 1,559 Eli Lilly shares in Q2 2026, an estimated $1.59M.
- Eli Lilly made up 0.1% of Mather Group's portfolio in Q2 2026, its #100 holding.
- Mather Group first reported a position in Eli Lilly in Q1 2021 and has held it in 22 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.